MAAETC-Addressing Cancer Screening and Care Considerations for the Transgender and Non-Binary Community

MidAtlantic AIDS Education Center (MAAETC)

Date: Jan 23, 2024 11:00 AM - 12:00 PM



CE Hours


CE Units


Registration closes on Jan 30, 2024 10:00 PM

Activity Type


Target Audience(s)



Accreditation Council for Pharmacy Education
Accreditation Statement: Howard University College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.


The MidAtlantic AIDS Education and Training Center (MAAETC) is supported by DHHS, Health Resources and Services Administration (HRSA) as part of a cooperative agreement of $2,917,621 and 0% financed with non-governmental sources. The program aims to provide HIV training and technical assistance to USPHS Region 3 (Pennsylvania, Maryland, Delaware, the District of Columbia, Virginia, and West Virginia). The contents in this presentation are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by HRSA, HHS, or the U.S. Government. For more information, please visit


Registration Closed  


  • State the types of gender affirming medical interventions transgender and non-binary persons may undergo.
  • Explain some of the social and environmental stressors persons who identify as transgender and non-binary may experience that can increase risk of HIV or cancer related diseases.
  • Describe barriers to access and quality of health care that transgender and non-binary patients may face and opportunities to dismantle systemic bias against sexual and gender minorities.
  • Outline the current evidenced based recommendations within the healthcare system for transgender and non-binary patients, as it relates to cancer related screening and treatment.


Maya Leiva, PharmD
APP Clinical Pharmacy Specialist-Hematology and Oncology, Inova Schar Cancer Institute

Activity Number

Date: 01/23/24
Time: 11:00 AM - 12:00 PM

CE Hours

Registration Closed